Albert David Ltd
NSE:ALBERTDAVD
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| IN |
|
Albert David Ltd
NSE:ALBERTDAVD
|
3.7B INR |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
934.4B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.8B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
262.7B CHF |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
238.2B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
221.2B GBP |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
284.1B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
150.2B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.4B USD |
Loading...
|
Market Distribution
| Min | -3 052.3% |
| 30th Percentile | 26.9% |
| Median | 39% |
| 70th Percentile | 53.3% |
| Max | 8 269.1% |
Other Profitability Ratios
Albert David Ltd
Glance View
Albert David Ltd. engages in the manufacture and trade of pharmaceuticals. The company is headquartered in Kolkata, West Bengal and currently employs 1,326 full-time employees. The company went IPO on 2016-06-14. The firm offers its products under various categories, which includes parenterals, oral/enteral, topical agents and vision care. Its parenterals consists of amino acids infusion, antimicrobial, anti-leishmaniasis (kalazar), hemostat, neurotropic vitamin and placenta extract. Its oral/enteral consists of amino acids oral, anthelmintic, anti-microbial, anti ulcerants, anti-vertigo, appetite stimulants, anti-tubercular, haematinics, oral vitamin b complex and expectorant / cough syrup. Its topical agents consist of non-steroidal anti-inflammatory drugs (NSAID). Its vision care consists of anti-glaucoma, anti-infective, tear substitutes and anti-infective with NSAID. The firm's plants are located at Gupta Lane, Kolkata and Meerut Road, Industrial Area, Ghaziabad.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Albert David Ltd is 64.9%, which is above its 3-year median of 64%.
Over the last 3 years, Albert David Ltd’s Gross Margin has increased from 64.2% to 64.9%. During this period, it reached a low of 58% on Mar 31, 2023 and a high of 67.4% on Dec 31, 2024.
